astragaloside a has been researched along with Diabetic Angiopathies in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, ZH; Lin, YX; Shen, GM; Wang, TT; You, LZ; Zhao, JD | 1 |
| Leng, B; Lu, M; Tang, F; Wang, H; Zhang, Y; Zhang, Z | 1 |
| Qi, F; Song, Z; Teng, J; Yin, Y; Zhang, B | 1 |
1 review(s) available for astragaloside a and Diabetic Angiopathies
| Article | Year |
|---|---|
[Research advances on astragaloside-IV in treatment of diabetes mellitus and its complications pharmacological effects].
Topics: Animals; Astragalus propinquus; Diabetes Complications; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Neuropathies; Drugs, Chinese Herbal; Humans; Medicine, Chinese Traditional; Saponins; Triterpenes | 2017 |
2 other study(ies) available for astragaloside a and Diabetic Angiopathies
| Article | Year |
|---|---|
Astragaloside IV improves vascular endothelial dysfunction by inhibiting the TLR4/NF-κB signaling pathway.
Topics: Animals; Cytokines; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Endothelium, Vascular; Male; NF-kappa B; Rats; Rats, Sprague-Dawley; Saponins; Signal Transduction; Toll-Like Receptor 4; Triterpenes | 2018 |
Ferulic acid combined with astragaloside IV protects against vascular endothelial dysfunction in diabetic rats.
Topics: Animals; Aorta, Abdominal; Coumaric Acids; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Drug Therapy, Combination; Endothelium, Vascular; Hypoglycemic Agents; Male; Molecular Structure; Rats, Wistar; Saponins; Triterpenes | 2014 |